These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33863282)

  • 1. Malignant hyperthermia when dantrolene is not readily available.
    Gong X
    BMC Anesthesiol; 2021 Apr; 21(1):119. PubMed ID: 33863282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands.
    Riazi S; Larach MG; Hu C; Wijeysundera D; Massey C; Kraeva N
    Anesth Analg; 2014 Feb; 118(2):381-387. PubMed ID: 23842196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications associated with the administration of dantrolene 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States.
    Brandom BW; Larach MG; Chen MS; Young MC
    Anesth Analg; 2011 May; 112(5):1115-23. PubMed ID: 21372281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The severity of sevoflurane-induced malignant hyperthermia.
    Migita T; Mukaida K; Kobayashi M; Hamada H; Kawamoto M
    Acta Anaesthesiol Scand; 2012 Mar; 56(3):351-6. PubMed ID: 22092278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006.
    Larach MG; Gronert GA; Allen GC; Brandom BW; Lehman EB
    Anesth Analg; 2010 Feb; 110(2):498-507. PubMed ID: 20081135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
    Miyazaki N; Kobayashi T; Komiya T; Okada T; Ishida Y; Fukui H; Ogihara Y; Uchino H
    J Med Case Rep; 2021 Apr; 15(1):201. PubMed ID: 33863374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Succinylcholine Use and Dantrolene Availability for Malignant Hyperthermia Treatment: Database Analyses and Systematic Review.
    Larach MG; Klumpner TT; Brandom BW; Vaughn MT; Belani KG; Herlich A; Kim TW; Limoncelli J; Riazi S; Sivak EL; Capacchione J; Mashman D; Kheterpal S; Kooij F; Wilczak J; Soto R; Berris J; Price Z; Lins S; Coles P; Harris JM; Cummings KC; Berman MF; Nanamori M; Adelman BT; Wedeven C; LaGorio J; McCormick PJ; Tom S; Aziz MF; Coffman T; Ellis TA; Molina S; Peterson W; Mackey SC; van Klei WA; Ginde AA; Biggs DA; Neuman MD; Craft RM; Pace NL; Paganelli WC; Durieux ME; Nair BJ; Wanderer JP; Miller SA; Helsten DL; Turnbull ZA; Schonberger RB;
    Anesthesiology; 2019 Jan; 130(1):41-54. PubMed ID: 30550426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant hyperthermia in a patient with Graves' disease during subtotal thyroidectomy.
    Nishiyama K; Kitahara A; Natsume H; Matsushita A; Nakano K; Sasaki S; Genma R; Yamamoto Y; Nakamura H
    Endocr J; 2001 Apr; 48(2):227-32. PubMed ID: 11456272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant Hyperthermia.
    Kaur H; Katyal N; Yelam A; Kumar K; Srivastava H; Govindarajan R
    Mo Med; 2019; 116(2):154-159. PubMed ID: 31040503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant hyperthermia.
    Halliday NJ
    J Craniofac Surg; 2003 Sep; 14(5):800-2. PubMed ID: 14501352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hyperthermia in Brazil: analysis of hotline activity in 2009.
    da Silva HC; Almeida Cdos S; Brandão JC; Nogueira e Silva CA; de Lorenzo ME; Ferreira CB; Resende AH; Barreira SR; de Almeida PA; Ferraro LH; Takeda A; de Oliveira KF; Lelis TG; Hortense A; Perez MV; Schmidt B; Oliveira AS; do Amaral JL
    Braz J Anesthesiol; 2013 Jan; 63(1):13-9. PubMed ID: 24565087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus Statement of the Malignant Hyperthermia Association of the United States on Unresolved Clinical Questions Concerning the Management of Patients With Malignant Hyperthermia.
    Litman RS; Smith VI; Larach MG; Mayes L; Shukry M; Theroux MC; Watt S; Wong CA
    Anesth Analg; 2019 Apr; 128(4):652-659. PubMed ID: 30768455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthermia in the pediatric intensive care unit--is it malignant hyperthermia?
    Schleelein LE; Litman RS
    Paediatr Anaesth; 2009 Nov; 19(11):1113-8. PubMed ID: 19694974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant hyperthermia in Mazovia Province - are we adequately prepared?
    Cieniewicz A; Trzebicki J
    Anaesthesiol Intensive Ther; 2022; 54(2):99-102. PubMed ID: 35579281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States.
    Larach MG; Brandom BW; Allen GC; Gronert GA; Lehman EB
    Anesth Analg; 2014 Dec; 119(6):1359-66. PubMed ID: 25268394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant hyperthermia.
    Ben Abraham R; Adnet P; Glauber V; Perel A
    Postgrad Med J; 1998 Jan; 74(867):11-7. PubMed ID: 9538480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous dantrolene in hypermetabolic syndromes: a survey of the U.S. Veterans Health Administration database.
    Caroff SN; Roberts CB; Rosenberg H; Tobin JR; Watt S; Mashman D; Riazi S; Berkowitz RM
    BMC Anesthesiol; 2022 Sep; 22(1):298. PubMed ID: 36123618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant hyperthermia in Brazil: analysis of hotline activity in 2009.
    Almeida da Silva HC; dos Santos Almeida C; Mendes Brandão JC; Nogueira e Silva CA; Pinto de Lorenzo ME; Duarte Ferreira CB; Resende AH; Barreira SR; de Almeida PA; Cunha Ferraro LH; Takeda A; de Oliveira KF; Lelis TG; Hortense A; Perez MV; Schmidt B; Bulle Oliveira AS; Gomes do Amaral JL
    Braz J Anesthesiol; 2013; 63(1):13-9. PubMed ID: 23438798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines.
    Glahn KPE; Bendixen D; Girard T; Hopkins PM; Johannsen S; Rüffert H; Snoeck MM; Urwyler A;
    Br J Anaesth; 2020 Aug; 125(2):133-140. PubMed ID: 32591088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant hyperthermia.
    Denborough M
    Lancet; 1998 Oct; 352(9134):1131-6. PubMed ID: 9798607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.